✦ LIBER ✦

Crumbling of left ventricular hypertrophy as a surrogate end point (the Losartan for Intervention for Endpoint Reduction in Hypertension [life] study)

✍ Scribed by Franz H Messerli; Mandeep R Mehra

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regression of hypertensive left ventricu

✍ R.B. Devereux; B. Dahlof; E. Gerdts 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Prognostic importance of hemoglobin in h

✍ Michael Hecht Olsen; Kristian Wachtell; Gareth Beevers; Björn Dahlöf; Richard B. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 314 KB

Body Build and Risk of Cardiovascular Ev

✍ G. de Simone; K. Wachtell; V. Palmieri 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Effects of losartan on cardiovascular mo

✍ S.E. Kjeldsen; B. Dahlor; R.B. Devereux 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Cost-effectiveness of losartan-based the

✍ McInnes, G; Burke, T A; Carides, G 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

H35 Baseline characteristics of the life

✍ B. Dahlöf; R. Devereux; U. DeFaire; F. Fyhrquist; T. Hedner; H. Ibsen; S. Julius 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 285 KB